Compare PSTV & BATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSTV | BATL |
|---|---|---|
| Founded | 1996 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5M | 27.1M |
| IPO Year | 2016 | 2004 |
| Metric | PSTV | BATL |
|---|---|---|
| Price | $3.78 | $1.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $55.00 | N/A |
| AVG Volume (30 Days) | 135.7K | ★ 16.2M |
| Earning Date | 05-29-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.61 | 42.56 |
| EPS | ★ N/A | N/A |
| Revenue | $5,213,000.00 | ★ $166,043,000.00 |
| Revenue This Year | $13.20 | N/A |
| Revenue Next Year | $261.48 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.13 | $1.00 |
| 52 Week High | $8.00 | $29.70 |
| Indicator | PSTV | BATL |
|---|---|---|
| Relative Strength Index (RSI) | 39.10 | 45.94 |
| Support Level | $3.64 | $1.06 |
| Resistance Level | $4.47 | $2.42 |
| Average True Range (ATR) | 0.25 | 0.25 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 27.38 | 9.52 |
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.